Soluble ST2 suppresses the effect of interleukin-33 on lung type 2 innate lymphoid cells

Type 2 innate lymphoid cells (ILC2) in lungs produce interleukin (IL)-5 and IL-13 in response to IL-33 and may contribute to the development of allergic diseases such as asthma. However, little is known about negative regulators and effective inhibitors controlling ILC2 function. Here, we show that...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayakawa, Hiroko, Hayakawa, Morisada, Tominaga, Shin-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600343/
https://www.ncbi.nlm.nih.gov/pubmed/28955848
http://dx.doi.org/10.1016/j.bbrep.2016.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600343/
https://www.ncbi.nlm.nih.gov/pubmed/28955848
http://dx.doi.org/10.1016/j.bbrep.2016.02.002

Ejemplares similares